202 related articles for article (PubMed ID: 37539706)
21. miR‑3664‑5P suppresses the proliferation and metastasis of gastric cancer by attenuating the NF‑κB signaling pathway through targeting MTDH.
Jiao Y; Yang H; Qian J; Gong Y; Liu H; Wu S; Cao L; Tang L
Int J Oncol; 2019 Mar; 54(3):845-858. PubMed ID: 30628643
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
23. Nalbuphine suppresses breast cancer stem-like properties and epithelial-mesenchymal transition via the AKT-NFκB signaling pathway.
Yu J; Luo Y; Wen Q
J Exp Clin Cancer Res; 2019 May; 38(1):197. PubMed ID: 31092275
[TBL] [Abstract][Full Text] [Related]
24. miR‑505 inhibits cell growth and EMT by targeting MAP3K3 through the AKT‑NFκB pathway in NSCLC cells.
Tang H; Lv W; Sun W; Bi Q; Hao Y
Int J Mol Med; 2019 Mar; 43(3):1203-1216. PubMed ID: 30628663
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
26. miR-516a-3p inhibits breast cancer cell growth and EMT by blocking the Pygo2/Wnt signalling pathway.
Chi Y; Wang F; Zhang T; Xu H; Zhang Y; Shan Z; Wu S; Fan Q; Sun Y
J Cell Mol Med; 2019 Sep; 23(9):6295-6307. PubMed ID: 31273950
[TBL] [Abstract][Full Text] [Related]
27. VEGF-C mediates tumor growth and metastasis through promoting EMT-epithelial breast cancer cell crosstalk.
Kong D; Zhou H; Neelakantan D; Hughes CJ; Hsu JY; Srinivasan RR; Lewis MT; Ford HL
Oncogene; 2021 Feb; 40(5):964-979. PubMed ID: 33299122
[TBL] [Abstract][Full Text] [Related]
28. The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway.
Zhang YP; Liu KL; Yang Z; Lu BS; Qi JC; Han ZW; Yin YW; Zhang M; Chen DM; Wang XW; Li W; Xin H
Cell Cycle; 2019 Oct; 18(19):2432-2446. PubMed ID: 31448674
[TBL] [Abstract][Full Text] [Related]
29. Long Non-Coding RNA (LncRNA) HOXA11-AS Promotes Breast Cancer Invasion and Metastasis by Regulating Epithelial-Mesenchymal Transition.
Li W; Jia G; Qu Y; Du Q; Liu B; Liu B
Med Sci Monit; 2017 Jul; 23():3393-3403. PubMed ID: 28701685
[TBL] [Abstract][Full Text] [Related]
30. Curcumin inhibits pancreatic cancer cell invasion and EMT by interfering with tumor‑stromal crosstalk under hypoxic conditions via the IL‑6/ERK/NF‑κB axis.
Li W; Sun L; Lei J; Wu Z; Ma Q; Wang Z
Oncol Rep; 2020 Jul; 44(1):382-392. PubMed ID: 32377752
[TBL] [Abstract][Full Text] [Related]
31. Long non‑coding RNA MEG3 suppresses epithelial‑to‑mesenchymal transition by inhibiting the PSAT1‑dependent GSK‑3β/Snail signaling pathway in esophageal squamous cell carcinoma.
Li MK; Liu LX; Zhang WY; Zhan HL; Chen RP; Feng JL; Wu LF
Oncol Rep; 2020 Nov; 44(5):2130-2142. PubMed ID: 32901893
[TBL] [Abstract][Full Text] [Related]
32. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
33. Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines.
Tsubaki M; Komai M; Fujimoto S; Itoh T; Imano M; Sakamoto K; Shimaoka H; Takeda T; Ogawa N; Mashimo K; Fujiwara D; Mukai J; Sakaguchi K; Satou T; Nishida S
J Exp Clin Cancer Res; 2013 Sep; 32(1):62. PubMed ID: 24011086
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA‑133b targets TGFβ receptor I to inhibit TGF‑β‑induced epithelial‑to‑mesenchymal transition and metastasis by suppressing the TGF‑β/SMAD pathway in breast cancer.
Wang S; Huang M; Wang Z; Wang W; Zhang Z; Qu S; Liu C
Int J Oncol; 2019 Nov; 55(5):1097-1109. PubMed ID: 31545407
[TBL] [Abstract][Full Text] [Related]
35. Cross-talk between SIM2s and NFκB regulates cyclooxygenase 2 expression in breast cancer.
Wyatt GL; Crump LS; Young CM; Wessells VM; McQueen CM; Wall SW; Gustafson TL; Fan YY; Chapkin RS; Porter WW; Lyons TR
Breast Cancer Res; 2019 Nov; 21(1):131. PubMed ID: 31783895
[TBL] [Abstract][Full Text] [Related]
36. Integrin-linked kinase overexpression promotes epithelial-mesenchymal transition via nuclear factor-κB signaling in colorectal cancer cells.
Shen H; Ma JL; Zhang Y; Deng GL; Qu YL; Wu XL; He JX; Zhang S; Zeng S
World J Gastroenterol; 2016 Apr; 22(15):3969-77. PubMed ID: 27099440
[TBL] [Abstract][Full Text] [Related]
37. MiR-466 as a poor prognostic predictor suppresses cell proliferation and EMT in breast cancer cells by targeting PSMA7.
Xiao Y; Zhang SJ; Yan X; Wu C; Liu QW; Dong HX; Wang LJ; Hu Y
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5625-5635. PubMed ID: 34604955
[TBL] [Abstract][Full Text] [Related]
38. Gemifloxacin inhibits migration and invasion and induces mesenchymal-epithelial transition in human breast adenocarcinoma cells.
Chen TC; Hsu YL; Tsai YC; Chang YW; Kuo PL; Chen YH
J Mol Med (Berl); 2014 Jan; 92(1):53-64. PubMed ID: 24005829
[TBL] [Abstract][Full Text] [Related]
39. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition.
Hsiao SY; Weng SM; Hsiao JR; Wu YY; Wu JE; Tung CH; Shen WL; Sun SF; Huang WT; Lin CY; Chen SH; Hong TM; Chen YL; Chang JY
J Exp Clin Cancer Res; 2023 Feb; 42(1):40. PubMed ID: 36737832
[TBL] [Abstract][Full Text] [Related]
40. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.
Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW
J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]